Hapyhair F 5% Solution is a topical formulation containing Minoxidil 5% w/v and Finasteride 0.1% w/v, indicated for the treatment of androgenetic alopecia in adult males. Minoxidil, a potent vasodilator, promotes hair follicle stimulation and prolongs the anagen phase of the hair growth cycle, thereby enhancing hair density and thickness. Finasteride, a selective 5-alpha-reductase inhibitor, reduces the conversion of testosterone to dihydrotestosterone (DHT), a key factor implicated in hair follicle miniaturization and progressive hair loss. The combined action of these agents provides a dual mechanism targeting both hair follicle stimulation and hormonal modulation, making Hapyhair F 5% Solution effective in slowing hair loss and promoting regrowth. The solution is applied topically to the affected scalp areas once daily, ensuring localized delivery with minimal systemic absorption. Patients should use the product consistently for several months to observe visible improvement. Common adverse effects may include scalp irritation, itching, or dryness. Use is contraindicated in women, particularly during pregnancy or lactation, due to the teratogenic potential of Finasteride. Prior consultation with a healthcare professional is recommended to evaluate suitability and monitor for potential side effects.